News|Articles|March 30, 2020

In the Lab eNewsletter

  • Pharmaceutical Technology's In the Lab eNewsletter-04-01-2020
  • Volume 15
  • Issue 4

MilliporeSigma Introduces a Digital Lab System for Improved Data Quality and Traceability

The Lanexo Lab Inventory, Safety, and Compliance Management System is a digital laboratory informatics solution formulated to reduce time in labs and improve data quality and traceability.

MilliporeSigma announced the launch of its Lanexo Lab Inventory, Safety, and Compliance Management System, a digital laboratory informatics solution formulated to reduce time in labs and improve data quality and traceability, in a March 3, 2020 press release

The company states that cloud-based system has the ability to document lab reagent data in real time through MilliporeSigma’s radio-frequency identification labels. The system also comes equipped with digitalized inventory, expiration, and storage monitoring and easy reagent identity checks and automatic alerts for assistance with avoiding expired reagents and minimizing experimental error.

“Today, 85% of labs are using paper or Excel to manage consumables data, and 25% of time is spent managing these data - taking scientists away from bench research,” said Jean-Charles Wirth, head of Applied Solutions at MilliporeSigma, in the press release. “Lab efficiency is critical as it gives scientists more time to focus on their research and analytics work and less on administrative tasks, which ultimately leads to faster drug development. Our [Lanexo] system - with first-to-market features - underscores MilliporeSigma’s commitment to advancing and commercializing laboratory informatics.”

Source: Millipore Sigma

 

 


Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.